Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001612042-26-000005
Filing Date
2026-05-07
Accepted
2026-05-07 07:45:22
Documents
73
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 6-K asnd-20260331.htm   iXBRL 6-K 2124892
2 GRAPHIC img253233243_0.gif GRAPHIC 39416
3 GRAPHIC img253233243_1.jpg GRAPHIC 153848
4 GRAPHIC img253233243_2.jpg GRAPHIC 136611
5 GRAPHIC img253233243_3.jpg GRAPHIC 1556460
6 GRAPHIC img253233243_4.jpg GRAPHIC 523038
7 GRAPHIC img253233243_5.jpg GRAPHIC 68861
8 GRAPHIC img253233243_6.jpg GRAPHIC 164115
9 GRAPHIC img253233243_7.jpg GRAPHIC 192260
10 GRAPHIC img253233243_8.jpg GRAPHIC 237070
11 GRAPHIC img253233243_9.jpg GRAPHIC 128430
12 GRAPHIC img253233243_10.jpg GRAPHIC 61198
13 GRAPHIC img253233243_11.jpg GRAPHIC 123574
14 GRAPHIC img253233243_12.jpg GRAPHIC 158877
15 GRAPHIC img253233243_13.jpg GRAPHIC 151439
16 GRAPHIC img253233243_14.jpg GRAPHIC 136509
17 GRAPHIC img253233243_15.jpg GRAPHIC 141051
18 GRAPHIC img253233243_16.jpg GRAPHIC 28301
19 GRAPHIC img253233243_17.jpg GRAPHIC 24087
  Complete submission text file 0001612042-26-000005.txt   17795791

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asnd-20260331.xsd EX-101.SCH 1260215
76 EXTRACTED XBRL INSTANCE DOCUMENT asnd-20260331_htm.xml XML 1409010
Mailing Address TUBORG BOULEVARD 12 HELLERUP Denmark
Business Address TUBORG BOULEVARD 12 HELLERUP Denmark 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 26950949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)